Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
filingDate |
2004-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7fa99d9823081a0ba1e0be8831df3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c645c803856fdda64cf206777cb3d28b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75dbc61198ca6da393c63bca83cbc27f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae4cd54682a4ba7bbd814715cb49296d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdf8e2c4918bfdff801104287c8298df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfa69348d25b40e623be806d1f245408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f70be0012964bd0f66a939c372c2e35d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d39e5dd07e2eec8351d0451c0b619fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5636df2eb998a36e7b59911ce6090856 |
publicationDate |
2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7378503-B2 |
titleOfInvention |
Antibodies against insulin-like growth factor 1 receptor and uses thereof |
abstract |
Antibodies which bind to IGF-IR and inhibit the binding of IGF-I and IGF-II to IGF-IR are characterized. These antibodies are implicated in anti-tumor therapy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009285824-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7850962-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010166747-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019046600-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011083391-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10035861-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7871611-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8852590-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011070615-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8460662-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8895008-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008260641-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168409-B2 |
priorityDate |
2003-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |